Hospital pharmacy and the patient

Proceedings of a symposium held at the University of York, England, 7–9 July 1982

Häftad, Engelska, 2012

1 459 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

The development of new technology means that compromised patients previously confined to hospital may now be treated at home.

Produktinformation

Utgivningsdatum2012-07-08
Mått155 x 235 x 12 mm
Vikt318 g
FormatHäftad
SpråkEngelska
Antal sidor187
FörlagSpringer
ISBN9789401197250

Tillhör följande kategorier

Apotek och farmaceuter inom Medicin
Medicin: allmänt inom Medicin

Section One Parenteral Therapy for the Patient at Home.- Chairman’s introduction.- 1 Cytotoxic therapy — developing a home intravenous service.- 2 Current therapeutic role of continuous insulin delivery systems.- 3 Care of the home parenteral nutrition patient.- 4 Is providing the regimen sufficient?.- Discussion.- Section Two Hazards, Risks and Responsibilities.- Chairman’s introduction.- 5 Handling cytotoxic drugs — health and safety hazards.- 6 Microbiological risks for the compromised patient at home.- 7 Home parenteral therapy and the general practice pharmacist.- 8 Home parenteral therapy and the hospital pharmacist.- Discussion.- Section Three New Approaches in Practice.- 9 An evaluation of the use of case studies in clinical pharmacy training.- Discussion.- 10 An integrated approach to ward pharmacy.- Discussion.- 11 Ward and clinical pharmacy — a comparison with Holland.- Discussion.- 12 The stability of diluted betamethasone 17-valerate topical preparations.- Discussion.- 13 A case study in nutritional support.- Discussion.- 14 The introduction of a cytotoxic reconstitution and additive service in a regional chemotherapy centre.- Discussion.- Section Four Drug Selection and Evaluation.- Chairman’s introduction.- 15 Hospital pharmacy and clinical pharmacokinetics — is academia in touch?.- 16 Theophylline therapy: the need for pharmacy involvement.- 17 Pharmacokinetics in the hospital pharmacy.- 18 Practising drug evaluation.- Discussion.- Closing address.